Effects of Vildagliptin Add-on Insulin Therapy on Nocturnal Glycemic Variations in Uncontrolled Type 2 Diabetes

被引：0
|
作者：
Feng-fei Li
Yun Shen
Rui Sun
Dan-feng Zhang
Xing Jin
Xiao-fang Zhai
Mao-yuan Chen
Xiao-fei Su
Jin-dan Wu
Lei Ye
Jian-hua Ma
机构：
[1] Nanjing Medical University,Department of Endocrinology, Nanjing First Hospital
[2] National Heart Research Institute Singapore,undefined
[3] National Heart Centre Singapore,undefined
来源：
Diabetes Therapy | 2017年 / 8卷
关键词：
Glycemic variations; Insulin; Type 2 diabetes; Vildagliptin;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：1111 / 1122
页数：11
相关论文
共 50 条
  • [41] Effect of Sitagliptin as Add-on Therapy in Elderly Type 2 Diabetes Patients With Inadequate Glycemic Control in Taiwan
    Chien, Ming-Nan
    Lee, Chun-Chuan
    Chen, Wei-Che
    Liu, Sung-Chen
    Leung, Ching-Hsiang
    Wang, Chao-Hung
    [J]. INTERNATIONAL JOURNAL OF GERONTOLOGY, 2011, 5 (02) : 103 - 106
  • [42] Erratum to: Evaluation of add-on therapy of sitagliptin in Japanese patients with type 2 diabetes under insulin therapy
    Tomoko Nakagami
    Risa Ide
    Naoko Iwasaki
    Makiko Ogata
    Junko Oya
    Mari Osawa
    Nobue Tanaka
    Hiroko Takaike
    Asako Sato
    Junnosuke Miura
    Yasuko Uchigata
    [J]. Diabetology International, 2014, 5 (3) : 198 - 198
  • [43] Pleiotropic effects of add-on therapy with pioglitazone, metformin or the combination of both in patients with type 2 diabetes on stable insulin glargine therapy
    Kleine, I. E.
    Fuchs, W.
    Pfuetzner, A.
    Forst, T.
    Hanefeld, M.
    [J]. DIABETOLOGIA, 2011, 54 : S374 - S374
  • [44] Mechanism Based Pharmacokinetic Pharmacodynamic Modeling of Vildagliptin as an Add-on to Metformin for Subjects with Type 2 Diabetes
    Eftekhari, Marziyeh
    Vahidi, Omid
    [J]. CMES-COMPUTER MODELING IN ENGINEERING & SCIENCES, 2018, 114 (02): : 153 - 171
  • [45] Real-World Use of Canagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Harris, Stewart B.
    Reichert, Sonja
    Mequanint, Selam M.
    Spaic, Tamara
    Esler, Jim
    [J]. DIABETES, 2017, 66 : A328 - A329
  • [46] Efficacy and safety of sitagliptin add-on therapy in Japanese patients with type 2 diabetes on insulin monotherapy
    Kadowaki T.
    Tajima N.
    Odawara M.
    Minamide T.
    Kawashima M.
    Yanagida D.
    Okamoto T.
    Arjona Ferreira J.C.
    [J]. Diabetology International, 2013, 4 (3) : 160 - 172
  • [47] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in people with Type 2 diabetes
    Duran-Garcia, S.
    Lee, J.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETIC MEDICINE, 2016, 33 (07) : 926 - 933
  • [48] Efficacy and safety of linagliptin as add-on therapy to basal insulin and metformin in patients with type 2 diabetes
    Lee, J.
    Duran-Garcia, S.
    Yki-Jarvinen, H.
    Rosenstock, J.
    Hehnke, U.
    Thiemann, S.
    Patel, S.
    Woerle, H. -J.
    [J]. DIABETOLOGIA, 2013, 56 : S355 - S355
  • [49] Real-World Use of Dapagliflozin as Add-On to Insulin Therapy in Patients with Type 2 Diabetes
    Spaic, Tamara
    Harris, Stewart B.
    Mequanint, Selam
    Reichert, Sonja
    Miller, Kristina
    [J]. DIABETES, 2017, 66 : A327 - A328
  • [50] Sitagliptin Add-On to Metformin plus Sulphonylurea Combination Therapy: The Efficacy of Triple Therapy on Glycemic Control in Type 2 Diabetes
    Sargin, Mehmet
    Tekin, Sakin
    Can, Ozgur
    Kisioglu, Savas Volkan
    Tekin, Buket Vatansever
    Orbay, Ekrem
    Tekce, Mustafa
    Aliustaoglu, Mehmet
    [J]. DIABETES, 2013, 62 : A669 - A670
12345